Effect of PPAR-Γ agonist-rosiglitazone-on adiponectin level in the metabolic syndrome

MLA

Mor Oron-Herman, et al. “Effect of PPAR-Γ Agonist-Rosiglitazone-on Adiponectin Level in the Metabolic Syndrome.” American Journal of Hypertension, vol. 18, May 2005, p. A204. EBSCOhost, https://doi.org/10.1016/j.amjhyper.2005.03.560.

APA

Mor Oron-Herman, Yehuda Kamari, Ehud Grossman, Yehonatan Sharabi, Irit Avni, & Edna Peleg. (2005). Effect of PPAR-Γ agonist-rosiglitazone-on adiponectin level in the metabolic syndrome. American Journal of Hypertension, 18, A204. https://doi.org/10.1016/j.amjhyper.2005.03.560

Chicago

Mor Oron-Herman, Yehuda Kamari, Ehud Grossman, Yehonatan Sharabi, Irit Avni, and Edna Peleg. 2005. “Effect of PPAR-Γ Agonist-Rosiglitazone-on Adiponectin Level in the Metabolic Syndrome.” American Journal of Hypertension 18 (May): A204. doi:10.1016/j.amjhyper.2005.03.560.